Piper Sandler Starts Solid Biosciences (SLDB) at Overweight

Piper Sandler analyst Biren Amin initiates coverage on Solid Biosciences (NASDAQ: SLDB) with a Overweight rating and a price target of $20.00.

For an analyst ratings summary and ratings history on Solid Biosciences click here. For more ratings news on Solid Biosciences click here.

Shares of Solid Biosciences closed at $7.64 yesterday.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Lucid Capital Markets Starts Core Scientific Inc. (CORZ) at Buy
• BofA Securities Resumes Williams-Sonoma (WSM) at Buy